Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Viatris has the lowest figure of the 61 pharmaceuticals ranked by earnings, at -PLN 14.1B, followed by Insmed (-PLN 5.1B) and Summit Therapeutics (-PLN 4.3B). Figures as of 18 Nov 2026, 15:49 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Viatris-PLN 14.1B
- Median
- PLN 237.3M
- Combined market value
- PLN 20.42T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ViatrisVTRS · Health Care | -PLN 14.1B | PLN 94.8B | PLN 82.65 | 0.49% up | 96% up | ||
| 2 | InsmedINSM · Health Care | -PLN 5.1B | PLN 105.1B | PLN 479.03 | 2.26% down | 40% down | ||
| 3 | Summit TherapeuticsSMMT · Health Care | -PLN 4.3B | PLN 34B | PLN 42.57 | 0.80% down | 36% down | ||
| 4 | Takeda PharmaceuticalTAK · Health Care | -PLN 3.8B | PLN 274.3B | PLN 85.87 | 1.34% down | 54% up | ||
| 5 | CytokineticsCYTK · Health Care | -PLN 3.2B | PLN 28.8B | PLN 206.93 | 0.39% down | 20% down | ||
| 6 | BridgeBio PharmaBBIO · Health Care | -PLN 2.9B | PLN 60.6B | PLN 311.01 | 0.69% up | 17% up | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | -PLN 1.5B | PLN 18.1B | PLN 108.71 | 0.26% up | 64% down | ||
| 8 | ABIVAXABVX · Health Care | -PLN 1.5B | PLN 29.5B | PLN 337.00 | 2.06% up | 27% down | ||
| 9 | Jazz PharmaceuticalsJAZZ · Health Care | -PLN 1.4B | PLN 62.4B | PLN 972.54 | 0.46% up | 37% up | ||
| 10 | Cogent BiosciencesCOGT · Health Care | -PLN 1.3B | PLN 19.8B | PLN 113.72 | 1.53% up | 20% down | ||
| 11 | Praxis Precision MedicinesPRAX · Health Care | -PLN 1.2B | PLN 34.2B | PLN 1,224.11 | 0.23% down | 61% up | ||
| 12 | Roivant SciencesROIV · Health Care | -PLN 1.2B | PLN 112.6B | PLN 155.45 | 0.15% down | 90% up | ||
| 13 | Legend BiotechLEGN · Health Care | -PLN 1.2B | PLN 12.6B | PLN 64.95 | 0.25% up | 42% down | ||
| 14 | Madrigal PharmaceuticalsMDGL · Health Care | -PLN 1.2B | PLN 38.7B | PLN 1,664.85 | 1.91% down | 24% down | ||
| 15 | Ascendis PharmaASND · Health Care | -PLN 1B | PLN 71.2B | PLN 1,085.59 | 0.47% down | 28% up | ||
| 16 | Elanco Animal HealthELAN · Health Care | -PLN 933.1M | PLN 52.9B | PLN 105.90 | 1.86% up | 20% up | ||
| 17 | Rhythm PharmaceuticalsRYTM · Health Care | -PLN 790.5M | PLN 32.6B | PLN 470.04 | 0.22% up | 13% up | ||
| 18 | Definium TherapeuticsDFTX · Health Care | -PLN 739.2M | PLN 15.7B | PLN 114.38 | 3.20% down | 169% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -PLN 736.7M | PLN 27.9B | PLN 529.83 | 3.10% down | 7% down | ||
| 20 | Edgewise TherapeuticsEWTX · Health Care | -PLN 674.9M | PLN 17.8B | PLN 162.81 | 3.71% down | 88% up | ||
| 21 | Dianthus TherapeuticsDNTH · Health Care | -PLN 652.9M | PLN 19.5B | PLN 345.48 | 1.24% down | 113% up | ||
| 22 | Spyre TherapeuticsSYRE · Health Care | -PLN 624.2M | PLN 35.9B | PLN 378.10 | 0.21% up | 286% up | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | -PLN 523.4M | PLN 32.8B | PLN 502.13 | 0.14% up | 46% up | ||
| 24 | ErascaERAS · Health Care | -PLN 500.9M | PLN 18.7B | PLN 53.17 | 4.82% down | 403% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -PLN 424M | PLN 26.2B | PLN 386.57 | 0.21% down | 241% up | ||
| 26 | Belite BioBLTE · Health Care | -PLN 312.1M | PLN 25.9B | PLN 638.28 | 0.62% up | 31% up | ||
| 27 | VeradermicsMANE · Health Care | -PLN 281.5M | PLN 21B | PLN 497.13 | 1.62% down | 233% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | -PLN 102.7M | PLN 19.3B | PLN 200.69 | 2.35% down | 44% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | -PLN 94M | PLN 23.9B | PLN 366.48 | 0.90% down | 31% up | ||
| 30 | Arrowhead PharmaceuticalsARWR · Health Care | -PLN 6.6M | PLN 24.5B | PLN 173.61 | 0.41% up | 10% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 237.3M | PLN 30.1B | PLN 383.37 | 0.22% up | 126% up | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | PLN 289.8M | PLN 30.1B | PLN 86.36 | 1.67% up | 83% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | PLN 400.8M | PLN 29.8B | PLN 272.08 | 3.45% down | 8% down | ||
| 34 | Ligand PharmaceuticalsLGND · Health Care | PLN 500.5M | PLN 23.7B | PLN 1,185.58 | 0.33% up | 43% up | ||
| 35 | AlkermesALKS · Health Care | PLN 972M | PLN 31.3B | PLN 186.27 | 1.90% up | 58% up | ||
| 36 | BeOne MedicinesONC · Health Care | PLN 1.2B | PLN 185.1B | PLN 1,620.23 | 2.52% down | 17% up | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | PLN 1.3B | PLN 82.5B | PLN 615.92 | 2.15% down | 66% down | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | PLN 1.4B | PLN 46.4B | PLN 239.65 | 1.84% up | 11% up | ||
| 39 | GrifolsGRFS · Health Care | PLN 1.8B | PLN 23.3B | PLN 34.29 | 1.22% down | 1% up | ||
| 40 | TG TherapeuticsTGTX · Health Care | PLN 1.8B | PLN 38.5B | PLN 254.67 | 0.97% up | 107% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 1.8B | PLN 50.2B | PLN 60.21 | 1.22% up | 5% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | PLN 2.7B | PLN 20.2B | PLN 241.90 | 0.36% down | 20% down | ||
| 43 | Royalty PharmaRPRX · Health Care | PLN 3.1B | PLN 158B | PLN 274.82 | 0.51% down | 78% up | ||
| 44 | GenmabGMAB · Health Care | PLN 3.9B | PLN 127.1B | PLN 206.09 | 1.38% down | 70% up | ||
| 45 | United TherapeuticsUTHR · Health Care | PLN 5.4B | PLN 98.1B | PLN 2,303.11 | 1.96% down | 23% up | ||
| 46 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 5.7B | PLN 198.1B | PLN 169.76 | 0.96% down | 74% up | ||
| 47 | ZoetisZTS · Health Care | PLN 10.8B | PLN 136.8B | PLN 336.75 | 0.30% up | 29% down | ||
| 48 | Vertex PharmaceuticalsVRTX · Health Care | PLN 15.9B | PLN 543.9B | PLN 2,145.23 | 0.15% down | 27% up | ||
| 49 | AbbVieABBV · Health Care | PLN 17B | PLN 2.05T | PLN 1,158.11 | 1.66% down | 26% up | ||
| 50 | Regeneron PharmaceuticalsREGN · Health Care | PLN 18.1B | PLN 397.6B | PLN 3,843.66 | 0.22% down | 36% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | PLN 26.2B | PLN 724.1B | PLN 418.08 | 0.73% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | PLN 28.4B | PLN 492.5B | PLN 240.95 | 2.35% down | 34% up | ||
| 53 | GSKGSK · Health Care | PLN 30.5B | PLN 393.7B | PLN 196.43 | 0.81% down | 6% up | ||
| 54 | PfizerPFE · Health Care | PLN 31.3B | PLN 644.1B | PLN 113.00 | 1.32% down | 14% up | ||
| 55 | SanofiSNY · Health Care | PLN 34.9B | PLN 456.5B | PLN 190.12 | 0.55% down | 4% down | ||
| 56 | AstraZenecaAZN · Health Care | PLN 41.1B | PLN 1.12T | PLN 719.48 | 1.85% down | 2% up | ||
| 57 | NovartisNVS · Health Care | PLN 56.2B | PLN 1.19T | PLN 628.54 | 1.79% down | 25% up | ||
| 58 | Novo NordiskNVO · Health Care | PLN 61.1B | PLN 701.2B | PLN 159.09 | 2.81% down | 17% down | ||
| 59 | Merck & CoMRK · Health Care | PLN 73.4B | PLN 1.38T | PLN 560.30 | 2.83% down | 51% up | ||
| 60 | Eli LillyLLY · Health Care | PLN 83B | PLN 4.97T | PLN 5,581.41 | 1.96% down | 35% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | PLN 107.8B | PLN 2.66T | PLN 1,105.30 | 1.39% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0219 PLN).
Questions and answers
Which pharmaceuticals have the lowest earnings?
Viatris (-PLN 14.1B), Insmed (-PLN 5.1B) and Summit Therapeutics (-PLN 4.3B) have the lowest earnings of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 15:49 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of PLN 20.42T as of 18 Nov 2026, 15:49 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.